| Literature DB >> 27325567 |
Terry-Ann M Milford1, Ruijun J Su1, Olivia L Francis1, Ineavely Baez1, Shannalee R Martinez1, Jacqueline S Coats1, Abby J Weldon2, Milcris N Calderon1, Michael C Nwosu1, Allen R Botimer1, Batul T Suterwala1, Xiao-Bing Zhang1, Christopher L Morris1, David J Weldon2, Sinisa Dovat3, Kimberly J Payne4.
Abstract
Thymic stromal lymphopoietin (TSLP) and IL-7 are cytokines that signal via the IL-7 receptor alpha (IL-7Rα) to exert both overlapping and unique functions during early stages of mouse B-cell development. In human B lymphopoiesis, the requirement for IL-7Rα signaling is controversial and the roles of IL-7 and TSLP are less clear. Here, we evaluated human B-cell production using novel in vitro and xenograft models of human B-cell development that provide selective IL-7 and human TSLP (hTSLP) stimulation. We show that in vitro human B-cell production is almost completely blocked in the absence of IL-7Rα stimulation, and that either TSLP or IL-7 can provide a signal critical for the production and proliferation of human CD19(+) PAX5(+) pro-B cells. Analysis of primary human bone marrow stromal cells shows that they express both IL-7 and TSLP, providing an in vivo source of these cytokines. We further show that the in vivo production of human pro-B cells under the influence of mouse IL-7 in a xenograft scenario is reduced by anti-IL-7 neutralizing antibodies, and that this loss can be restored by hTSLP at physiological levels. These data establish the importance of IL-7Rα mediated signals for normal human B-cell production.Entities:
Keywords: Human B lymphopoiesis; IL-7; Pro-B cell; TSLP; Xenograft
Mesh:
Substances:
Year: 2016 PMID: 27325567 PMCID: PMC5056642 DOI: 10.1002/eji.201646307
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532